Literature DB >> 12578798

Efficacy of the female condom as a barrier to semen during intercourse.

Maurizio Macaluso1, M Louise Lawson, Glen Hortin, Ann Duerr, Karen R Hammond, Richard Blackwell, Amy Bloom.   

Abstract

In 1996-1998, the authors measured prostate-specific antigen (PSA) in vaginal fluid to assess the frequency of female condom failure and to evaluate the association of self-reported failure with semen exposure. Women at low risk of sexually transmitted diseases (n = 210) were recruited in Birmingham, Alabama. They were trained to use the female condom, sample vaginal fluid before and after condom use, and complete forms to report problems during each use. Semen exposure was assessed by comparing pre- and postcoital PSA levels in vaginal fluid. A total of 175 women used 2,232 condoms. The rate of semen exposure ranged from 7% to 21% of condom uses, depending on the exposure criterion. Exposure was more likely (21-34%) and more intense (mean postcoital PSA, 24.7 ng/ml) if participants reported a mechanical problem versus other problems or no problems (exposure rate, 5-20% in both instances; mean postcoital PSA, 9.6 and 7.8 ng/ml, respectively). In logistic regression analyses for repeated measurements, user-reported problems accounted for less than 59% of the instances of semen exposure. The female condom prevented semen exposure in 79-93% of condom uses. Exposure was associated with user-reported problems but also occurred in their absence. Reported problems and semen exposure decreased with user experience.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578798     DOI: 10.1093/aje/kwf212

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  22 in total

1.  Objective non-intrusive markers of sperm production and sexual activity.

Authors:  Thilee Sivananthan; Franz Bathur; Mark Jimenez; Ann Conway; Amanda Idan; David Handelsman
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

2.  Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA.

Authors:  Roxanne Jamshidi; Ana Penman-Aguilar; Jeffrey Wiener; Maria F Gallo; Jonathan M Zenilman; J H Melendez; Margaret Snead; Carolyn M Black; Denise J Jamieson; Maurizio Macaluso
Journal:  Contraception       Date:  2013-08-14       Impact factor: 3.375

Review 3.  Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions.

Authors:  A M Minnis; N S Padian
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

4.  Reducing HIV/AIDS transmission among African-American females: is the female condom a solution?

Authors:  Samatha Brown; Yolanda Wimberly
Journal:  J Natl Med Assoc       Date:  2005-10       Impact factor: 1.798

5.  Prostate-specific antigen concentration in vaginal fluid after exposure to semen.

Authors:  Andrzej Kulczycki; Ilene Brill; Margaret Christine Snead; Maurizio Macaluso
Journal:  Contraception       Date:  2017-07-12       Impact factor: 3.375

6.  The use of biomarkers of semen exposure in sexual and reproductive health studies.

Authors:  Margaret Christine Snead; Carolyn M Black; Athena P Kourtis
Journal:  J Womens Health (Larchmt)       Date:  2014-09-30       Impact factor: 2.681

7.  Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance.

Authors:  Terri Walsh; Lee Warner; Maurizio Macaluso; Ron Frezieres; Margaret Snead; Brian Wraxall
Journal:  Contraception       Date:  2012-03-02       Impact factor: 3.375

8.  Building young women's knowledge and skills in female condom use: lessons learned from a South African intervention.

Authors:  A C Schuyler; T B Masvawure; J A Smit; M Beksinska; Z Mabude; C Ngoloyi; J E Mantell
Journal:  Health Educ Res       Date:  2016-03-08

Review 9.  Translation of biomedical prevention strategies for HIV: prospects and pitfalls.

Authors:  Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

10.  Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards.

Authors:  Margaret C Snead; Athena P Kourtis; Carolyn M Black; Christine K Mauck; Teresa M Brown; Ana Penman-Aguilar; Johan H Melendez; Maria F Gallo; Denise J Jamieson; Maurizio Macaluso
Journal:  Contraception       Date:  2012-12-04       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.